Fourteen lines, four small groups
A comprehensive metabolic panel is fourteen lines, and they are not fourteen independent verdicts. They are four groups that happen to travel on the same tube: the electrolytes (sodium, potassium, chloride, bicarbonate), two kidney lines (urea and creatinine, with an estimated filtration rate calculated from them), six liver lines (albumin, total protein, alkaline phosphatase, ALT, AST, bilirubin), and finally glucose and calcium.
A basic metabolic panel is the same sheet with the six liver lines taken out. If your report shows eight lines rather than fourteen, nothing was forgotten: a different panel was ordered.
Reading it group by group is not a tidy habit, it is the only way the numbers mean anything. Creatinine is read next to urea. Albumin is read next to total protein. Calcium is read against albumin, because much of the calcium in blood is bound to it, and a low albumin drags the calcium down with it without anything being wrong with your calcium.
Potassium is the line most often wrong
Potassium sits inside red cells at roughly thirty times its concentration in the plasma around them. Break a few of those cells anywhere between your arm and the analyser and the potassium in the tube rises without anything having happened to you. Laboratories track this with a haemolysis index, and a verification study across twenty-six chemistry tests confirmed potassium among the values haemolysis pushes upward, alongside AST, LDH, bilirubin and iron, while glucose and ALT are pushed down.
The causes are mechanical and mundane: a tourniquet left on too long, a fist clenched and pumped during the draw, a narrow needle, a shaken tube, a delay before the sample is spun. European sampling guidance addresses several of them directly, asking that the tourniquet come off as soon as blood flows and that pumping the fist be avoided.
So a potassium flagged slightly high on an otherwise ordinary panel has a boring first explanation, and the usual next step is another draw rather than a treatment.
A low sodium is often a medicine
Mild hyponatraemia is one of the commonest abnormalities on a routine panel, and in people treated for blood pressure the explanation is frequently on their own prescription. A cohort of 2 613 adults newly treated for hypertension found that among those who stayed on a thiazide diuretic, roughly three in ten developed a sodium at or below 130 mmol/L.
That is not a reason to stop the tablet. It is a reason for the number to be read next to the medicine list rather than on its own, and for the doctor who prescribed it to be the one who decides what follows.
The same logic runs through the whole panel. Many of these lines move with the drugs you take, with what you drank, and with how long you sat before the needle went in.
The filtration rate is an estimate, not a measurement
The eGFR printed under your creatinine was never measured. It is calculated from the creatinine, your age and your sex, using an equation, and it carries the uncertainty of an equation.
That equation changed recently, and the change matters when you compare reports. In 2021 a joint task force of the National Kidney Foundation and the American Society of Nephrology recommended that United States laboratories immediately adopt the CKD-EPI creatinine equation refitted without the race variable, and that cystatin C be used more routinely to confirm the estimate in people at risk of kidney disease.
The practical consequence: an eGFR on an older report may not be directly comparable with a recent one, and a single value below a threshold calls for a repeat rather than a conclusion.